Artificial intelligence applications in thyroid cancer care
View abstract on PubMed
Summary
This summary is machine-generated.Artificial intelligence (AI) offers significant potential to enhance thyroid cancer diagnosis and management. However, widespread clinical adoption requires more high-quality, independent validation of AI tools in trials.
Area Of Science
- Medical Informatics
- Oncology
- Artificial Intelligence
Background
- Artificial intelligence (AI) presents numerous opportunities to advance thyroid cancer care.
- AI applications are rapidly evolving in the diagnosis and management of thyroid cancer.
Purpose Of The Study
- To review key applications of AI in thyroid cancer diagnosis and management.
- To highlight impactful research and discuss the evolution of AI in thyroid cancer care.
- To address current limitations and future directions for AI implementation in thyroid cancer.
Main Methods
- PubMed database search using the query "artificial intelligence thyroid cancer" until May 31, 2025.
- Selection of high-impact publications based on technical innovation, dataset size, and validation rigor.
- Review of AI applications including computer vision for ultrasound, metastasis detection, digital pathology, and large language models.
Main Results
- Computer vision for thyroid ultrasound nodule evaluation is a primary focus with significant clinical potential.
- AI shows promise in detecting lymph node metastases, analyzing pathology slides, and processing unstructured data.
- Current limitations include a lack of prospective validation, uncertain clinical utility, and implementation challenges.
Conclusions
- AI is poised to improve thyroid cancer diagnosis, lower costs, and enable personalized treatment.
- High-quality, independent prospective validation is crucial for broad clinical adoption of AI in thyroid cancer.
Related Concept Videos
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...

